PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years

Journal of Clinical Microbiology

Volumn 52, Issue 9, 2014, Pages 3156-3163

  Haugum, K ^a   Brandal, L T ^b   Lindstedt, B A ^c   Wester, A L ^b   Bergh, K ^a,d   Afset, J E ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; EAEA PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; VEROTOXIN 1; VEROTOXIN 2; VIRULENCE FACTOR;

ADOLESCENT; BACTERIUM; CHILD; CLASSIFICATION; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETICS; GENOTYPE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MOLECULAR DIAGNOSIS; MOLECULAR TYPING; NEWBORN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROCEDURES; SEROTYPING; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ADHESINS, BACTERIAL; ADOLESCENT; BACTERIA; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SEROTYPING; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84906877827     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00453-14     Document Type: Article

References (50)

1. Karmali MA, Steele BT, Petric M, Lim C. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i:619-620.
2. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685. http://dx.doi.org/10.1056/NEJM198303243081203.
3. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85(13 Suppl):E45-E62. http://dx.doi.org/10.2527/jas.2006-508.
4. European Centre for Disease Prevention and Control. 2013. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. European Centre for Disease Prevention and Control, Stockholm, Sweden.
5. Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, White PL, Wymore K, Gierke RE, Mahon BE, Griffin RM, Emerging Infections Program Foodnet Working Group. 2013. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog. Dis. 10:453-460. http://dx.doi.org/10. 1089/fpd.2012.1401.
6. Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. Dis. 43:1160-1167. http://dx.doi.org/10.1086/508195.
7. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84. http://dx.doi.org/10.1086/338115.
8. Persson S, Olsen KE, Ethelberg S, Scheutz F. 2007. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J. Clin. Microbiol. 45:2020-2024. http://dx.doi.org/10. 1128/JCM.02591-06.
9. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, Karch H, Mellmann A, Caprioli A, Tozzoli R, Morabito S, Strockbine NA, Melton-Celsa AR, Sanchez M, Persson S, O'Brien AD. 2012. Multicenter evaluation of a sequence-based protocol for subtyping shiga toxins and standardizing stx nomenclature. J. Clin. Microbiol. 50:2951-2963. http://dx.doi.org/10.1128/JCM.00860-12.
10. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
11. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940. http://dx.doi.org/10.1128/JCM.41.11.4930-4940.2003.
12. Bugarel M, Martin A, Fach P, Beutin L. 2011. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 11:142. http://dx.doi.org/10.1186/1471-2180-11-142.
13. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA. 2008. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 74:2153-2160. http://dx.doi.org/10.1128/AEM.02566-07.
14. Bugarel M, Beutin L, Martin A, Gill A, Fach P. 2010. Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with hemorrhagic colitis and hemolytic uremic syndrome in humans. Int. J. Food Microbiol. 142:318-329. http://dx.doi.org/10.1016/j.ijfoodmicro. 2010.07.010.
15. Johnson TJ, Nolan LK. 2009. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol. Mol. Biol. Rev. 73:750-774. http://dx.doi.org/10. 1128/MMBR.00015-09.
16. March SB, Ratnam S. 1986. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol. 23:869-872.
17. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, Carey R, Crandall C, Hurd S, Kaplan R, Neill M, Shea S, Somsel P, Tobin-D'Angelo M, Griffin PM, Gerner-Smidt P. 2009. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm. Rep. 58(RR-12):1-14.
18. Gould LH. 2012. Update: recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. Clin. Microbiol. Newsl. 34:75-83. http://dx.doi.org/10.1016/j.clinmicnews.2012.04.004.
19. Karch H, Bielaszewska M, Bitzan M, Schmidt H. 1999. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn. Microbiol. Infect. Dis. 34:229-243. http://dx.doi.org/10.1016/S0732-8893(99) 00031-0.
20. Bielaszewska M, Kock R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2:e1024. http://dx.doi.org/10.1371/ journal.pone.0001024.
21. Brian MJ, Frosolono M, Murray BE, Miranda A, Lopez EL, Gomez HF, Cleary TG. 1992. Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J. Clin. Microbiol. 30:1801-1806.
22. Gannon VP, Rashed M, King RK, Thomas EJ. 1993. Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction. J. Clin. Microbiol. 31:1268-1274.
23. Nielsen EM, Andersen MT. 2003. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5′ nuclease PCR assay. J. Clin. Microbiol. 41:2884-2893. http://dx.doi.org/10.1128/JCM.41.7. 2884-2893.2003.
24. Brandal LT, Lindstedt BA, Aas L, Stavnes TL, Lassen J, Kapperud G. 2007. Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. J. Microbiol. Methods 68:331-341. http://dx.doi.org/10.1016/j.mimet.2006.09.013.
25. Brandal LT, Sekse C, Lindstedt BA, Sunde M, Lobersli I, Urdahl AM, Kapperud G. 2012. Norwegian sheep are an important reservoir for human-pathogenic Escherichia coli O26:H11. Appl. Environ. Microbiol. 78:4083-4091. http://dx.doi.org/10.1128/AEM.00186-12.
26. Jelacic JK, Damrow T, Chen GS, Jelacic S, Bielaszewska M, Ciol M, Carvalho HM, Melton-Celsa AR, O'Brien AD, Tarr PI. 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188:719-729. http://dx.doi.org/10.1086/376999.
27. Rüssmann H, Schmidt H, Heesemann J, Caprioli A, Karch H. 1994. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J. Med. Microbiol. 40:338-343. http://dx.doi.org/10.1099/00222615-40-5-338.
28. Lindstedt BA, Vardund T, Kapperud G. 2004. Multiple-Locus Variable-Number Tandem-Repeats Analysis of Escherichia coli O157 using PCR multiplexing and multi-colored capillary electrophoresis. J. Microbiol. Methods 58:213-222. http://dx.doi.org/10.1016/j.mimet.2004.03.016.
29. Lindstedt BA, Brandal LT, Aas L, Vardund T, Kapperud G. 2007. Study of polymorphic variable-number of tandem repeats loci in the ECOR collection and in a set of pathogenic Escherichia coli and Shigella isolates for use in a genotyping assay. J. Microbiol. Methods 69:197-205. http://dx.doi.org/10.1016/j. mimet.2007.01.001.
30. Lindstedt BA. 2011. Genotyping of selected bacterial enteropathogens in Norway. Int. J. Med. Microbiol. 301:648-653. http://dx.doi.org/10.1016/j.ijmm. 2011.09.005.
31. Bugarel M, Beutin L, Fach P. 2010. Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl. Environ. Microbiol. 76:203-211. http://dx.doi.org/10.1128/AEM.01921-09.
32. Nicholls L, Grant TH, Robins-Browne RM. 2000. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35:275-288. http://dx.doi.org/10.1046/j.1365-2958.2000.01690.x.
33. Centers for Disease Control and Prevention. 2012. National Shiga toxin-producing Escherichia coli (STEC) surveillance annual summary, 2009. CDC, Atlanta, GA.
34. European Centre for Disease Prevention and Control, European Food Safety Authority. 2011. Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104. European Centre for Disease Prevention and Control, Stockholm, Sweden.
35. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. 2013. Recent advances in understanding enteric pathogenic escherichia coli. Clin. Microbiol. Rev. 26:822-880. http://dx.doi.org/10.1128/CMR.00022-13.
36. - causes another outbreak of haemolytic uraemic syndrome in children. Epidemiol. Infect. 137:389-395. http://dx.doi.org/10.1017/ S0950268808001465.
37. Rosser T, Dransfield T, Allison L, Hanson M, Holden N, Evans J, Naylor S, La Ragione R, Low JC, Gally DL. 2008. Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM. Infect. Immun. 76:5598-5607. http://dx.doi.org/10.1128/IAI.01180-08.
38. Melton-Celsa A, Mohawk K, Teel L, O'Brien A. 2012. Pathogenesis of Shiga-toxin producing Escherichia coli. Curr. Top. Microbiol. Immunol. 357:67-103. http://dx.doi.org/10.1007/82-2011-176.
39. Delannoy S, Beutin L, Fach P. 2013. Towards a molecular definition of enterohemorrhagic Escherichia coli (EHEC): detection of genes located on O island 57 as markers to distinguish EHEC from closely related enteropathogenic E. coli strains. J. Clin. Microbiol. 51:1083-1088. http://dx.doi.org/10.1128/ JCM.02864-12.
40. Johnson KE, Thorpe CM, Sears CL. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595. http://dx.doi.org/10.1086/509573.
41. Friedrich AW, Zhang W, Bielaszewska M, Mellmann A, Kock R, Fruth A, Tschape H, Karch H. 2007. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin. Infect. Dis. 45:39-45. http://dx.doi.org/ 10.1086/518573.
42. Mellmann A, Lu S, Karch H, Xu JG, Harmsen D, Schmidt MA, Bielaszewska M. 2008. Recycling of Shiga toxin 2 genes in sorbitolfermenting enterohemorrhagic Escherichia coli O157:NM. Appl. Environ. Microbiol. 74:67-72. http://dx.doi.org/10.1128/AEM.01906-07.
43. Mellmann A, Bielaszewska M, Kock R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. 2008. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 14:1287-1290. http://dx.doi.org/10.3201/eid1408.071082.
44. Karch H, Friedrich AW, Gerber A, Zimmerhackl LB, Schmidt MA, Bielaszewska M. 2006. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin. Thromb. Hemost. 32:105-112. http://dx.doi.org/10.1055/s-2006- 939766.
45. Buvens G, Pierard D. 2012. Virulence profiling and disease association of verocytotoxin-producing Escherichia coli O157 and non-O157 isolates in Belgium. Foodborne Pathog. Dis. 9:530-535. http://dx.doi.org/10.1089/fpd.2011.1073.
46. Kawano K, Ono H, Iwashita O, Kurogi M, Haga T, Maeda K, Goto Y. 2012. stx genotype and molecular epidemiological analyses of Shiga toxin-producing Escherichia coli O157:H7/H- in human and cattle isolates. Eur. J. Clin. Microbiol. Infect. Dis. 31:119-127. http://dx.doi.org/10.1007/s10096-011-1283-1.
47. Pradel N, Bertin Y, Martin C, Livrelli V. 2008. Molecular analysis of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France. Appl. Environ. Microbiol. 74:2118-2128. http://dx.doi.org/10.1128/AEM.02688-07.
48. Khan F, Proulx F, Lingwood CA. 2009. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int. 75:1209-1216. http://dx.doi.org/10.1038/ki.2009.7.
49. Wahl E, Vold L, Lindstedt BA, Bruheim T, Afset JE. 2011. Investigation of an Escherichia coli O145 outbreak in a child day-care centre - extensive sampling and characterization of eae- and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infect. Dis. 11:238. http://dx.doi.org/10.1186/1471-2334-11-238.
50. Schimmer B, Nygard K, Eriksen HM, Lassen J, Lindstedt BA, Brandal LT, Kapperud G, Aavitsland P. 2008. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect. Dis. 8:41. http://dx.doi.org/10.1186/1471-2334-8-41.